Experience with the use of basiliximab in liver transplantation--use in pediatric and adult recipients in combination with cyclosporine or tacrolimus

Transplant Proc. 2002 Aug;34(5):1966-7. doi: 10.1016/s0041-1345(02)03142-1.
No abstract available

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Age Factors
  • Antibodies, Monoclonal / therapeutic use*
  • Basiliximab
  • Child
  • Cyclosporine / therapeutic use*
  • Drug Therapy, Combination
  • Follow-Up Studies
  • Graft Survival
  • Humans
  • Immunosuppressive Agents / blood
  • Immunosuppressive Agents / pharmacokinetics
  • Immunosuppressive Agents / therapeutic use
  • Liver Transplantation / immunology*
  • Liver Transplantation / mortality
  • Recombinant Fusion Proteins*
  • Retrospective Studies
  • Survival Rate
  • Tacrolimus / blood
  • Tacrolimus / pharmacokinetics
  • Tacrolimus / therapeutic use*
  • Time Factors

Substances

  • Antibodies, Monoclonal
  • Immunosuppressive Agents
  • Recombinant Fusion Proteins
  • Cyclosporine
  • Basiliximab
  • Tacrolimus